... the riskoftype2diabetes mellitus (type 2 DM) in ecological and migrant studies [1 ;2] . However, data on associations between total meat andtypeof meat intake and the riskoftype2 DM ... intake, and the riskoftype2diabetes in women. Arch Intern Med 20 04; 164 (20 ) :22 35 -22 40. 6. Schulze MB, Manson JE, Willett WC, Hu FB. Processed meat intake and incidence ofType2diabetes ... 32. 3 42. 3 34.3 38.9 31.8 38.3 Up to High School 21 .9 31.9 23 .7 30.6 21 .1 33.8 22 .8 29 .3 College 9 .2 16.1 10.8 15.5 8.5 17.3 12. 6 14.1 Income Level (%) <10000 21 .5 13.7 20 .2 14.4 22 .1 12. 3...
... of people from 20 03 to 20 52 2003 20 52 Fig. 15. Number of people in Slovenia from 20 03 to 20 52 0 10 20 30 40 50 60 70 80 90 10001000 20 003000400050006000age [yeas]number 20 03 20 52 ... (20 05). Pre- diabetes essential action: a European perspective, Diabetes & Metabolism, Vol 31, No. 6, 20 05, pp. 606- 620 , ISSN 126 2-3636, doi : DM- 12- 2005-31-6- 126 2-3636-101019- 20 05163 42. ... Fig. 16. Number of D2 patients from 20 03 to 20 52 Topics in the Prevention, Treatment and Complications ofType2Diabetes 28 WHO - World health organization (20 11b), Obesity and overweight,...
... Manifestations of chronic disease during pregnancy. Jama 20 05, 29 4 :27 51 -27 57.49. Kim C, Newton KM, Knopp RH: Gestational diabetesand the incidence of type2 diabetes: a systematic review. Diabetes ... consistency of care with guidelines and relationship to clinical outcomes. Chest 20 03, 124 :29 7-305. 24 . Diagnosis and classification ofdiabetes mellitus. Diabetes Care 20 08, 31:S55-60. 25 . Levy ... Diabetes Care 20 02, 25 :18 62- 1868.50. Ben-Haroush A, Yogev Y, Hod M: Epidemiology of gestational diabetes mellitus and its association with Type2 diabetes. Diabet Med 20 04, 21 :103-113.51....
... Role of the Adipocyte in Development ofType2Diabetes 16effects (Tang et al., 20 01), acting as co-adjuvants in the reduction of the incident ofdiabetes (Doggrell, 20 02) , increasing ... several diseases including Type2 diabetes (Scheuner & Kaufman, 20 08), Tumor hypoxia and prognosis (Koumenis & Wouters, 20 06), Alzheimer´s (Kudo et al., 20 06) and Parkinson´s Disease ... tolerance to type2 diabetes: the Finnish Diabetes Prevention Study. Diabetes Vol. 52, No. 7 (July 20 03), pp. 18 72- 76. Kudo T, Katayama T, Imaizumi K, Yasuda Y, Yatera M, et al. (20 02) . The unfolded...
... Complications ofType2Diabetes 22 Foti, M.et al. (20 04). Insulin and IGF-1 receptor trafficking and signalling. Novartis Found Symp, Vol. 26 2, No. pp. 125 -141; discussion 141- 127 , 26 5- 128 Gembal, ... future riskoftype2 diabetes. Diabetes/ Metabolism Research and Reviews, Vol .26 , No.4, (May 20 10), pp. 28 0 -28 6, ISSN: 1 520 -75 52 American Diabetes Association. (1997). Report of the Expert ... (20 09). Development of a type2diabetesrisk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care, Vol. 32, No.7, (July 20 09), pp. 120 7- 121 2, ISSN: 0149-59 92 Kramer C.K.,...
... type2 diabetes. However, many studies of HRQOL in people with type 2 diabetes are now including both a diabetes- specific and ageneral measure of HRQOL [ 12, 26]. Finally, the samplesize of 21 7 ... purposes)Background Type 2diabetes mellitus (type 2 diabetes) affects approxi-mately 10% of the U.S. population aged 20 years and older and its prevalence increases with age [1]. Peoplewith type2diabetes ... models 3 and 4 attenuated theassociation oftype2diabetesand vitality. An improve-Table 1: Characteristics ofand health-related quality of life in participants with and without type2 diabetes Characteristic...
... with type 2 diabetes. The scope of the problem. Diabetes Care 20 05, 28 :25 43 -25 45.9. Meece J: Dispelling myths and removing barriers about insulinin type2 diabetes. Diabetes Educator 20 06, 32( 1):9S-18S.10. ... patients with type 2 diabetes mellitus: progressive requirement for multipletherapies (UKPDS49). JAMA 20 12, 28 1 :20 05-1999. 2. Chan JL, Abrahamson MJ: Pharmacological management of type 2diabetes ... appraisal of insulin therapy and depressionin insulin-naïve patients with type2 diabetes. Diabetes 20 07,A504:19 92- P.19. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of co-morbid...